Compounds of Formula (I): ##STR00001## or pharmaceutically acceptable
salts, solvates, or esters thereof, are useful in treating diseases or
conditions mediated by CB.sub.1 receptors, such as metabolic syndrome and
obesity, neuroinflammatory disorders, cognitive disorders and psychosis,
addiction (e.g., smoking cessation), gastrointestinal disorders, and
cardiovascular conditions.